Dorsey & Whitney Trust CO LLC raised its position in shares of CME Group (NASDAQ:CME) by 30.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,080 shares of the financial services provider’s stock after buying an additional 960 shares during the period. Dorsey & Whitney Trust CO LLC’s holdings in CME Group were worth $660,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also recently bought and sold shares of CME. ARK Investment Management LLC acquired a new stake in shares of CME Group during the fourth quarter worth approximately $120,000. AlphaOne Investment Services LLC bought a new stake in shares of CME Group during the fourth quarter valued at approximately $146,000. Mosaic Family Wealth LLC bought a new stake in shares of CME Group during the fourth quarter valued at approximately $146,000. Truewealth LLC bought a new stake in shares of CME Group during the fourth quarter valued at approximately $157,000. Finally, Captrust Financial Advisors bought a new stake in shares of CME Group during the fourth quarter valued at approximately $186,000. 83.10% of the stock is owned by institutional investors.
In related news, CFO John W. Pietrowicz sold 2,500 shares of the firm’s stock in a transaction on Tuesday, April 10th. The shares were sold at an average price of $161.02, for a total transaction of $402,550.00. Following the sale, the chief financial officer now directly owns 34,957 shares in the company, valued at $5,628,776.14. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Hilda Harris Piell sold 3,299 shares of the firm’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $163.52, for a total transaction of $539,452.48. The disclosure for this sale can be found here. Company insiders own 0.45% of the company’s stock.
Shares of NASDAQ CME opened at $160.45 on Wednesday. The firm has a market cap of $54.66 billion, a PE ratio of 29.82, a PEG ratio of 2.26 and a beta of 0.57. CME Group has a twelve month low of $159.34 and a twelve month high of $161.35. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.10.
CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, April 26th. The financial services provider reported $1.86 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.01. The company had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $1.12 billion. CME Group had a net margin of 111.45% and a return on equity of 8.48%. The business’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same period last year, the firm posted $1.22 earnings per share. equities analysts anticipate that CME Group will post 6.79 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Monday, June 25th. Stockholders of record on Friday, June 8th will be given a dividend of $0.70 per share. The ex-dividend date of this dividend is Thursday, June 7th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.75%. CME Group’s dividend payout ratio is 58.70%.
CME has been the topic of several research analyst reports. ValuEngine raised shares of CME Group from a “hold” rating to a “buy” rating in a research note on Monday, April 2nd. Goldman Sachs raised shares of CME Group from a “neutral” rating to a “buy” rating and set a $180.00 price target on the stock in a research note on Wednesday, February 7th. BidaskClub cut shares of CME Group from a “strong-buy” rating to a “buy” rating in a research note on Thursday, March 15th. Bank of America increased their price target on shares of CME Group from $175.00 to $185.00 and gave the company a “buy” rating in a research note on Thursday, March 8th. Finally, Sandler O’Neill reissued a “buy” rating and set a $175.00 price target on shares of CME Group in a research note on Friday, February 2nd. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $165.57.
CME Group Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.